Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa Pneumonia
Clinical trial NCT03027609 · COMPLETED
Trial details
- NCT number
- NCT03027609
- Sponsor
- Aridis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-29
- Primary completion
- 2019-04-25
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.